Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Preclinical and clinical data on p53 presented at AACR

April 17, 1997

C225 effective in mouse model of human bladder cancer

April 16, 1997

ImClone reports research results from its anti-flk-1 monoclonal antibody program

April 16, 1997

Oxford Molecular Group and ImmunoGen join efforts in humanized antibody development

April 16, 1997

DiagnoCure licenses growth factor derivatives for cancer diagnosis/therapy

April 16, 1997

Pola discloses antitumor/immunosuppressive agents

April 16, 1997

Antitumor indane derivatives from Taiho

April 16, 1997

Nippon Kayaku isolates novel antitumor agents

April 16, 1997

Natural interferon gamma introduced in Japan

April 15, 1997

TGF-beta1 antisense vaccine effective in rat prostate cancer model

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...